Isoflurane hyperalgesia is modulated by nicotinic inhibition

Area of Science:

• Anesthesiology
• Neuroscience
• Pain Research

Background:

• Inhaled anesthetic isoflurane affects neuronal nicotinic acetylcholine receptors (nAChRs) at sub-anesthetic concentrations.
• Isoflurane exhibits biphasic effects on pain, causing both hyperalgesia and analgesia.
• Nicotinic agonists are known analgesics, prompting investigation into isoflurane's mechanism.

Purpose of the Study:

• To investigate the hypothesis that isoflurane-induced hyperalgesia results from the inhibition of nicotinic neurotransmission.
• To elucidate the role of nAChRs in mediating the pain responses to sub-anesthetic doses of isoflurane.

Main Methods:

• Experiments were conducted on female mice using hind paw withdrawal latency measurements.
• Mice received intraperitoneal injections of nicotinic agonists, antagonists, or saline at varying isoflurane concentrations.
• In vitro studies examined the interaction between isoflurane and mecamylamine/nicotine on alpha(4)beta(2) nAChRs.

Main Results:

• Isoflurane induced significant hyperalgesia in female mice.
• Nicotine administration blocked isoflurane-induced hyperalgesia but did not affect isoflurane's antinociceptive properties at higher concentrations.
• Mecamylamine, a nicotinic antagonist, mimicked isoflurane's hyperalgesic effects and potentiated them additively in vivo and in vitro.

Conclusions:

• Isoflurane's inhibition of nAChR activation is implicated in the pathway leading to hyperalgesia.
• Sub-anesthetic doses of isoflurane can produce either hyperalgesia or analgesia, depending on the concentration.
• Findings suggest a critical role for nAChRs in modulating pain perception during isoflurane anesthesia.